Q2 2021 Vitrolife AB Earnings Call Transcript

Jul 15, 2021 / 08:00AM GMT
Operator

Good day, and thank you for standing by, and welcome to the interim report January-June 2021. (Operator Instructions)

For your information, the conference is being recorded.

Now I would like to hand the conference over to your speaker, Thomas Axelsson. Please go ahead.

Thomas Axelsson - Vitrolife AB(publ)-CEO

Thank you very much, and welcome to the Interim Report January-June 2021. The speakers today will be Mikael Engblom, he's the CFO of the company; and myself, Thomas Axelsson, that is CEO of the company.

Please change page to them and go into the summary of the Q2. Q2, it was a quarter of good growth. Sales was SEK 382 million, and that was a growth in 83% in Swedish currency. Sales increased by 94% in local currency and the EBITDA with a margin of 39%, excluding onetime cost. I would also within -- together with Mikael in this interim report go through -- and happening after the closing date. And that is the announcement of an agreement to acquire 100% of Igenomix.

Please change page

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot